Hepatitis B core-related antigen: a strong indicator for cessation of nucleos(t)ide analog therapy in patients with chronic hepatitis B

J Gastroenterol. 2017 Jan;52(1):127-128. doi: 10.1007/s00535-016-1259-0. Epub 2016 Sep 24.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents / administration & dosage*
  • DNA, Viral / blood*
  • Hepatitis B Core Antigens / blood*
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Nucleosides / administration & dosage

Substances

  • Antiviral Agents
  • DNA, Viral
  • Hepatitis B Core Antigens
  • Nucleosides